Dr. Amaliris Gonzalez
Shortly before graduating from Temple University with a Bachelors in Biology, Dr. Gonzales was recruited to the NSF funded Bridge to the Doctorate Program to obtain a PhD. Her thesis focused on a developmental time-course study on day-blind canines with mutations in the retinal cyclic-nucleotide-gated channel β-subunit. The work was part of a corrective gene therapy study for achromatopsia at the University of Pennsylvania's veterinary school. For her post-doctoral training, she has joined the gene therapy team in Dr. Stefano Rivella's laboratory, led by Dr. Laura Breda. Dr. Gonzalez is interested in developing strategies that target transferrin receptors, using lentivirus vectors, miRNA and CAR-T cell technology, to ameliorate symptoms of beta-thalassemia and sickle cell anemia.